<bill session="115" type="s" number="1062" updated="2019-04-26T14:00:49Z">
  <state datetime="2017-05-04">REFERRED</state>
  <status>
    <introduced datetime="2017-05-04"/>
  </status>
  <introduced datetime="2017-05-04"/>
  <titles>
    <title type="official" as="introduced">A bill to increase reporting transparency and accountability with respect to Food and Drug Administration user fees.</title>
    <title type="short" as="introduced">FDA Reporting Transparency and Accountability Act</title>
    <title type="short" as="introduced">FDA Reporting Transparency and Accountability Act</title>
    <title type="display">FDA Reporting Transparency and Accountability Act</title>
  </titles>
  <sponsor bioguide_id="B001135"/>
  <cosponsors>
    <cosponsor bioguide_id="Y000064" joined="2017-05-04"/>
  </cosponsors>
  <actions>
    <action datetime="2017-05-04">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2017-05-04" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="SSHR" name="Senate Health, Education, Labor, and Pensions" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill type="h" session="115" relation="unknown" number="2430"/>
    <bill type="s" session="115" relation="unknown" number="934"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Computers and information technology"/>
    <term name="Congressional oversight"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Food and Drug Administration (FDA)"/>
    <term name="Government buildings, facilities, and property"/>
    <term name="Government employee pay, benefits, personnel management"/>
    <term name="Government information and archives"/>
    <term name="Licensing and registrations"/>
    <term name="Performance measurement"/>
    <term name="Prescription drugs"/>
    <term name="Public contracts and procurement"/>
    <term name="Public participation and lobbying"/>
    <term name="User charges and fees"/>
  </subjects>
  <amendments/>
  <summary date="2017-05-04T04:00:00Z" status="Introduced in Senate">FDA Reporting Transparency and Accountability Act

This bill expands reporting requirements related to the performance of the Food and Drug Administration (FDA), including to require additional information on timeliness and personnel and publication every 30 days of information regarding FDA guidance and meetings.</summary>
  <committee-reports/>
</bill>
